This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2007
Title: Jean-Claude Ameisen: Innovator in Cell Death Induction
Introduction
Jean-Claude Ameisen is a prominent inventor based in Paris, France. He is known for his significant contributions to the field of cell biology, particularly in the area of inducing cell death. His innovative work has implications for medical research and therapeutic applications.
Latest Patents
Ameisen holds a patent for the "Use of novel agents inducing cell death in synergy with interferons." This invention focuses on the use of novel agents that promote cell death, specifically an agent that facilitates the overexpression of the PML protein in nuclear bodies. When combined with interferons, this approach aims to induce the death of undesirable cells and stimulate an immune response.
Career Highlights
Throughout his career, Jean-Claude Ameisen has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the National Institute of Health and Medical Research. His research has been pivotal in advancing our understanding of cellular processes and their applications in medicine.
Collaborations
Ameisen has collaborated with notable colleagues, including Frédérique Quignon and Hugues De The. Their joint efforts have contributed to the advancement of knowledge in the field of cell death and immune response.
Conclusion
Jean-Claude Ameisen's innovative work in the induction of cell death represents a significant advancement in medical research. His contributions continue to influence the field and hold promise for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile